Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551152-25-000040
Filing Date
2025-08-04
Accepted
2025-08-04 15:17:04
Documents
83
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abbv-20250630.htm   iXBRL 10-Q 2314296
2 EX-31.1 abbv-20250630xex311.htm EX-31.1 9175
3 EX-31.2 abbv-20250630xex312.htm EX-31.2 9264
4 EX-32.1 abbv-20250630xex321.htm EX-32.1 4751
5 EX-32.2 abbv-20250630xex322.htm EX-32.2 4748
11 abbv-20250630_g1.jpg GRAPHIC 15145
12 abbv-20250630_g2.gif GRAPHIC 748
  Complete submission text file 0001551152-25-000040.txt   11604161

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20250630.xsd EX-101.SCH 59437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20250630_cal.xml EX-101.CAL 88737
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20250630_def.xml EX-101.DEF 373415
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20250630_lab.xml EX-101.LAB 822773
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20250630_pre.xml EX-101.PRE 584305
86 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20250630_htm.xml XML 2277546
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 251179739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)